Il Yang Pharmaceutical Co. Preferred (007575)
Market Open
11 Aug, 06:30
KRX SM KRX SM Primary ₩
7,900. 00
+120
+1.5424%
₩
319.63B Market Cap
- P/E Ratio
175% Div Yield
394 Volume
- Eps
₩ 7,780
Previous Close Want to track 007575 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
007575 trading today higher at ₩7,900, an increase of 1.5424% from yesterday's close, completing a monthly increase of 8.3676% or ₩610. Over the past 12 months, 007575 stock lost -39.1371%.
007575 pays dividends to its shareholders, with the most recent payment made on Apr 27, 2026. The next estimated payment will be in In 8 months on Apr 27, 2027 for a total of ₩175.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Il Yang Pharmaceutical Co. Preferred has completed 1 stock splits, with the recent split occurring on Jun 28, 2006.
The company's stock is traded on one exchange.
Il Yang Pharmaceutical Co. Preferred (007575) FAQ
What is the stock price today?
The current price is ₩7,900.00.
On which exchange is it traded?
Il Yang Pharmaceutical Co. Preferred is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 007575.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 175%.
What is its market cap?
As of today, the market cap is 319.63B.
Has Il Yang Pharmaceutical Co. Preferred ever had a stock split?
Il Yang Pharmaceutical Co. Preferred had 1 splits and the recent split was on Jun 28, 2006.
Il Yang Pharmaceutical Co. Preferred Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Dong-Yeon Kim CEO | KRX SM Exchange | KR7007571003 ISIN |
| KR Country | 666 Employees | 27 Dec 2024 Last Dividend | 28 Jun 2006 Last Split | - IPO Date |
Overview
Ilyang Pharmaceutical Co.,Ltd, with its foundation laid in 1946 and headquartered in Yongin, South Korea, stands as a distinguished entity in the pharmaceutical territory, primarily catering to the South Korean market. Initially known as Il-Yang Pharm. Ind. Co., the company underwent a rebranding in May 1991 to its current nomenclature. Its operational spectrum encompasses the development, manufacture, and commercialization of a wide array of pharmaceutical products, spanning over various therapeutic areas. Notably, the company's prowess extends beyond national borders, marking its presence in the international pharmaceutical arena through exports.
Products and Services
Ilyang Pharmaceutical Co.,Ltd's product portfolio is broad and diverse, covering a multitude of therapeutic categories and auxiliary sectors within the pharmaceutical and healthcare industry:
- Anticancer, Circulatory System, Endocrine/Metabolism, Cheonjiyang, Female Hormone, Urinary System, Ophthalmology, Liver Disease, Anti-inflammatory Analgesic, Digestive System, Dermatology, Respiratory System, Nutrient Infusion, and Neurology Medicines: These product lines underscore the company's commitment to addressing a wide range of health conditions, from chronic diseases such as cancer, and conditions of the circulatory and endocrine systems, to acute ailments requiring anti-inflammatory analgesics and nutrient infusions.
- Antibiotics, Antifungal Drugs, and Antiviral Medications: These segments highlight the company's role in combating infectious diseases, offering a variety of treatments against bacterial, fungal, and viral infections.
- Insecticides and Vaccines: Contributing to public health and preventive medicine, Ilyang provides solutions for pest control and immunization against infectious diseases.
- Health Drinks, Daily Food, Supplements, Health Food, Cosmetics, and Beverages: Diversifying into the wellness and personal care sectors, the company offers a range of products that promote general well-being, nutritional supplements, and skin-care potions.
- Pharmaceutical Raw Materials: Ilyang Pharmaceutical Co., Ltd. also specializes in the provision of a comprehensive selection of pharmaceutical raw materials, such as various forms of aluminum hydroxide gel, magnesium hydroxide, and other compounds essential for pharmaceutical manufacturing.
Contact Information
Address: 110, Hagal-ro, Yongin, South Korea, 17096
Phone: 82 3 1281 7851
Website: https://home.ilyang.co.kr
